Evaxion Biotech A/S is developing treatment candidates for various cancer conditions.
According to a marketresearch reportby Grand View Research, the global market for melanoma therapeutics is expected to reach $11 billion by 2025.
This represents a forecast CAGR (Compound Annual Growth Rate) of 11.21%. I hold for it.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
rally today ... up up up